Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125858341 | 12585834 | 1 | I | 20160713 | 20160725 | 20160725 | PER | US-ASTRAZENECA-2016SE77175 | ASTRAZENECA | 59.00 | YR | F | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125858341 | 12585834 | 1 | PS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | TWO TIMES PER DAY, ONE-HALF OF ONE-HALF A TABLET IN THE MORNING, AND 2 TO 2 AND ONE-HALF TABLETS ... | 20639 | TABLET | |||||||||
125858341 | 12585834 | 2 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Unknown | EVERY MORNING | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125858341 | 12585834 | 1 | Sleep disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125858341 | 12585834 | Gait disturbance | |
125858341 | 12585834 | Hypothyroidism | |
125858341 | 12585834 | Off label use | |
125858341 | 12585834 | Product use issue | |
125858341 | 12585834 | Restless legs syndrome | |
125858341 | 12585834 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |